Institutions / Euclidean Capital LLC

Euclidean Capital LLC

CIK 1825034 · Institution · as of Dec 31, 2025

Portfolio value

$369.45M

Positions

As of

Dec 31, 2025

Top holdings

Dec 31, 2025

Company	Class	Value	Shares	% of portfolio
Vanguard Intl Equity Index F	—	$219.95M	2,990,084	59.5%
Vanguard Index Fds	—	$99.31M	520,000	26.9%
iShares MSCI UAE ETF	—	$19.98M	369,600	5.4%
Foghorn Therapeutics Inc.	—	$8.50M	1,573,761	2.3%
Oric Pharmaceuticals, Inc.	—	$8.09M	989,410	2.2%
PMV Pharmaceuticals, Inc.PMVP	Common Stock	$3.28M	2,627,643	0.9%
SPDR S&P 500 ETF Tr	—	$2.80M	4,104	0.8%
Rapt Therapeutics Inc	—	$2.79M	82,234	0.8%
Alector, Inc.	—	$2.04M	1,307,858	0.6%
Surrozen, Inc./DESRZN	Common Stock	$1.98M	87,696	0.5%
Tenaya Therapeutics, Inc.TNYA	Common Stock	$722.7K	1,015,705	0.2%
Surrozen Inc	—	$3.4K	170,833	0.0%

Activity

Dec 31, 2025

InsidersInstitutions

This fund's 13F position changes — what it's buying and selling.

No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.